All.Can around the world

All.Can UK

All.Can UK is a partnership between Bristol-Myers Squibb and The Patients Association.

Cancer care in the UK

Cancer costs the UK more than £16bn a year. While the UK spends more money on healthcare than the rest of Europe, it allocates far less of its health spending to cancer (3.8%) than the EU average (5%).1

Despite this, incidence of cancer is rising and survival lags behind much of Europe.2, 3 The UK’s National Health Service (NHS) is also facing increasing demands on its services, caused by an ageing population and lifestyle factors such as obesity and smoking. This growing pressure on NHS services is forcing it to seek further efficiencies year on year.

Half of all British people (under 65 years) will receive a cancer diagnosis during their lifetime.4 The NHS has set itself the target of radically improving cancer outcomes over the next five years,5 while developments in the diagnosis and treatment of cancer have the potential to help people live better for longer. While investment is required to enable greater efficiencies in the NHS, with no additional funding immediately available we need to examine how we can potentially deliver more for less. To do so, we need to break the negative cycle of cancer care, where a short-term approach can often lead to longer-term costs.1

All.Can UK initiative

All.Can UK launched the national initiative Breaking the Cycle in Cancer Care to respond to this negative cycle in cancer care and examine how we can deliver cancer services more effectively. The initiative in the UK is run as a partnership between Bristol-Myers Squibb and The Patients Association, a leading charity that champions patient interests, and brings together patient groups and experts from the cancer community to examine how the NHS can deliver the best possible care for patients with cancer, in the context of wider financial challenges for the NHS.

The aim of this work is to identify the current problems facing cancer services and develop recommendations to help improve patient care through best-practice implementation and long-term thinking.

Activities and milestones

All.Can UK held its first expert Working Group meeting in December 2016, which led to the development of the report, Transforming the Cycle in Cancer Care.

The report was launched in Parliament on 22 March 2017. It sets out recommendations for transforming cancer care by identifying and implementing existing best practice throughout the NHS. It shows that improving efficiency is not just about cutting costs, but rather focusing resources on delivering what matters most to patients.

An animation and a fact sheet based on the report have been published to support the dissemination of its key messages.

 

References:

1. Cole, A, Lundqvist A, Lorgelly P, et al. Office of Health Economics, UK, and Swedish Institute for Health Economics Sweden, 2016. Improving Efficiency and Resource Allocation in Future Cancer Care, available here: https://www.ohe.org/publications/improving-efficiency-and-resource-allocation-future-cancer-care [accessed: August 2017]
2. Cancer Research UK, Cancer Incidence, available here: http://www.cancerresearchuk.org/health-professional/cancer-statistics/incidence [accessed: August 2017]
3. Macmillan, ‘Our cancer survival must match Europe’s best’, available here: http://www.macmillan.org.uk/documents/getinvolved/campaigns/patientoutcomes/cancer-survival-leaflet.pdf [accessed: August 2017]
4. Ahmad AS, Ormiston-Smith N, Sasieni PD. Trends in the lifetime risk of developing cancer in Great Britain: Comparison of risk for those born in 1930 to 1960. Br J Cancer 2015; 112: 943-947
5. National Health Service, 2016. Achieving World-Class Cancer Outcomes: Taking the Strategy Forward. Available at: https://www.england.nhs.uk/wp-content/uploads/2016/05/cancer-strategy.pdf [accessed: August 2017]

 

Job Bag: ONCUK1701040-01
Date created: September 2017

Disclaimer:

The UK All.Can initiative and the development of the Transforming the Cycle in Cancer Care report, video and materials have been developed in partnership with The Patients Association and funded by Bristol-Myers Squibb UK.

    

 

All.Can is a trademark of The Health Policy Partnership Limited.

A range of health charities from across the cancer community have inputted into the development of this programme and the UK initiative has been supported and developed in partnership with the leading national charity The Patients Association.

Resources